Macrophage infiltrate and prognosis in c-erbB-2-overexpressing breast carcinomas

Journal of Clinical Oncology

Volumn 14, Issue 1, 1996, Pages 85-94

  Pupa, S M ^a   Bufalino, R ^a   Invernizzi, A M ^a   Andreola, S ^a   Rilke, F ^a   Lombardi, L ^a   Colnaghi, M I ^a   Menard S ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN;

ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER SIZE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MACROPHAGE; MAJOR CLINICAL STUDY; MASTECTOMY; MENOPAUSE; ONCOGENE C ERB; PRIORITY JOURNAL; PROGNOSIS; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE;

EID: 0030030349     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.1.85     Document Type: Article

References (34)

1. Vose BM, Moore M: Human tumor-infiltrating lymphocytes: A marker of host response. Semin Hematol 22:27-40, 1985
2. Johnson JP, Riethmuller G, Schirrmacher V: Tumor immunology: Paul Ehrlich's heritage. Immunol Today 10:S35-S37, 1989
3. Black MM, Hankey BF, Barclay THC: Intrastage prognostic heterogeneity: Implications for adjuvant chemotherapy of breast cancer. J Natl Cancer Inst 68:445-447, 1982
4. Elston CW, Gresham GA, Rao GS, et al: The cancer research campaign (King's/Cambridge) trial for early breast cancer: Clinicopathologic aspects. Br J Cancer 45:655-669, 1982
5. Champion HR, Wallace IWJ, Prescott RJ: Histology in breast cancer prognosis. Br J Cancer 26:129-138, 1972
6. 0) breast cancer. Am J Clin Pathol 78:817-823, 1982
7. 0) breast carcinoma: A study of 644 patients with median follow-up of 18 years. J Clin Oncol 7:1239-1251, 1989
8. O'Sullivan C, Lewis CE: Tumour-associated leucocytes: Friends or foes in breast carcinoma. J Pathol 172:229-235, 1994
9. Bottazzi B, Polentarutti N, Acero R, et al: Regulation of the macrophage content of neoplasma by chemoattractants. Science 220:210-212, 1983
10. Graves DT, Jiang YL, Williamson MJ: Identification of monocyte chemotactic activity produced by malignant cells. Science 245:1490-1493, 1989
11. Mantovani A, Bottazzi B, Colotta F, et al: The origin and function of tumor-associated macrophages. Immunol Today 13:265-270, 1992
12. Scholl SM, Pallud C, Beuvon F, et al: Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis. J Natl Cancer Inst 86:120-126, 1994
13. Gottlinger HG, Rieber P, Gokel JM, et al: Infiltrating mononuclear cells in human breast carcinoma: Predominance of T4+ monocytic cells in the tumor stroma. Int J Cancer 35:199-205, 1985
14. Horst H-A, Horny H-P: Characterization and frequency distribution of lymphoreticular infiltrates in axillary lymph node metastases of invasive ductal carcinoma of the breast. Cancer 60:3001-3007, 1987
15. + macrophages in antitumor cytotoxicity. Lab Invest 67:166-174, 1992
16. Tang RP, Kacinski B, Validire I, et al: Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers: A role for hematopoietic growth factor release by tumor cells? J Cell Biochem 44:189-198, 1990
17. Rilke F, Colnaghi MI, Cascinelli N, et al: Prognostic significance of HER-2/neu expression in breast cancer and its relationship to other prognostic factors. Int J Cancer 49:44-49, 1991
18. Slamon DJ, Press MF, Godolphin W, et al: Studies of the HER2/neu proto-oncogene in human breast cancer, in Furth M, Greaves M (eds): Cancer Cells, 7-Molecular Diagnostics of Human Cancer. New York, NY, Cold Spring Harbor Laboratory, 1989, pp 371-384
19. Pupa SM, Ménard S, Andreola S, et al: Antibody response against the c-erbB-2 oncoprotein in breast carcinoma patients. Cancer Res 53:5864-5866, 1993
20. Disis ML, Calenoff E, McLaughlin G, et al: Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer. Cancer Res 54:16-20, 1994
21. Harmanek P, Sobin LH: TNM Classification of Malignant Tumors. UICC International Union Against Cancer. Berlin, Germany, Springer-Verlag, 1987
22. Bloom HJG, Richardson WW: Histological grading and prognosis in breast cancer. Br J Cancer 11:359-377, 1957
23. Carter D, Elkins RC, Pipkin RD, et al: Relationship of necrosis and tumor border to lymphnode metastases and 10-year survival in carcinoma of the breast. Am J Surg Pathol 2:39-46, 1978
24. Mariani-Costantini R, Barbanti P, Colnaghi MI, et al: Reactivity of a monoclonal antibody with tissues and tumors from human breast: Immunohistochemical localization of a new antigen and clinico-pathologic correlations. Am J Pathol 115:47-56, 1984
25. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 34:585-612, 1976
26. Cox DR: Regression models and life tables. J R Stat Soc 34:187-220, 1972
27. Aaltomaa S, Lipponen P. Eskelinen M, et al: Lymphocyte infiltrates as a prognostic variable in female breast cancer. Eur J Cancer 28A:859-864, 1992
28. Naukkarinen A, Syrjänen KJ: Quantitative immunohistochemical analysis of mononuclear infiltrates in breast carcinomas-correlation with tumor differentiation. J Pathol 160:217-222, 1990
29. Bhan AK, Des Marais CL: Immunohistologic characterization of major histocompatibility antigens and inflammatory cellular infiltrate in human breast cancer. J Natl Cancer Inst 71:507-516, 1983
30. Giorno R: Mononuclear cells in malignant and benign human breast tissue. Arch Pathol Lab Med 107:415-417, 1983
31. Wintzer H-O, Bohle W, Von Kleist S: Study of the relationship between immunohistologically demonstrated lymphocytes infiltrating human breast carcinomas and patients' survival. J Cancer Res Clin Oncol 117:163-167, 1991
32. Melani C, Pupa SM, Ménard S, et al: An in vivo model to compare human leukocyte infiltration in carcinoma xenografts producing different chemokines. Int J Cancer (in press)
33. Oppenheim JJ, Zachariae COC, Mukaida N, et al: Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol 9:617-648, 1991
34. Naylor MS, Stamp GWH, Balkwill FR: Investigation of cytokine gene expression in human colorectal cancer. Cancer Res 50:4436-4440, 1990